Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,000
Closed -$1K 10237
2025
Q3
$1K Sell
3,000
-6,800
-69% -$2.8K ﹤0.01% 8902
2025
Q2
$4K Sell
9,800
-39,500
-80% -$17.2K ﹤0.01% 7908
2025
Q1
$20K Buy
49,300
+13,800
+39% +$8.85K ﹤0.01% 6598
2024
Q4
$23K Sell
35,500
-31,000
-47% -$21.5K ﹤0.01% 6593
2024
Q3
$56K Sell
66,500
-11,000
-14% -$8.41K ﹤0.01% 5793
2024
Q2
$51K Buy
77,500
+8,000
+12% +$6.64K ﹤0.01% 6074
2024
Q1
$90K Buy
69,500
+64,000
+1,164% +$67.1K ﹤0.01% 5698
2023
Q4
$3K Sell
5,500
-400
-7% -$276 ﹤0.01% 8173
2023
Q3
$4K Sell
5,900
-3,400
-37% -$2.59K ﹤0.01% 7822
2023
Q2
$6K Sell
9,300
-1,400
-13% -$1.3K ﹤0.01% 7852
2023
Q1
$8K Sell
10,700
-34,000
-76% -$31.6K ﹤0.01% 7756
2022
Q4
$42K Sell
44,700
-46,300
-51% -$65.4K ﹤0.01% 6090
2022
Q3
$198K Buy
91,000
+1,400
+2% +$4.83K ﹤0.01% 4623
2022
Q2
$313K Sell
89,600
-20,700
-19% -$77.3K ﹤0.01% 4051
2022
Q1
$555K Buy
110,300
+48,100
+77% +$244K ﹤0.01% 3716
2021
Q4
$389K Sell
62,200
-314,500
-83% -$2.15M ﹤0.01% 4172
2021
Q3
$2.89M Buy
376,700
+24,600
+7% +$202K ﹤0.01% 1716
2021
Q2
$2.64M Buy
352,100
+351,085
+34,590% +$2.45M ﹤0.01% 1817
2021
Q1
$614K Buy
+1,015
New +$7.81K ﹤0.01% 3069

Other funds holding VXRT

Simplex Trading's VXRT Position: Q4 2025 in Review

Simplex Trading sold out of Vaxart (VXRT) in Q4 2025, closing a stake of 18,592 shares — an estimated $6K sold.

Simplex Trading first reported a position in VXRT in Q1 2015 and held it in 22 quarters. The position peaked at $401K in Q3 2021. 5 funds tracked by Wall St. Rank hold VXRT as of Q4 2025.

  • Simplex Trading reported no remaining Vaxart position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 18,592 Vaxart shares in Q4 2025, an estimated $6K.
  • Simplex Trading first reported a position in Vaxart in Q1 2015 and held it in 22 quarters.
  • Simplex Trading's Vaxart position peaked at $401K in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Vaxart as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.